The Venture Codex Logo

The Venture Codex

AIHC Capital

Unit 1506, 15th Floor, Nexxus Building, 41 Connaught Road Central, Central, 999077, Hong Kong

Overview

Asset management company focused on healthcare sector investments.

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series B
Series D

Geographic focus

China
Hong Kong
Russian Federation
South Africa
...

Sector focus

—

Investment portfolio

8rounds
NAMEDATESIZE
Orange Dental
Jan 2024Participated
$130 MSeries B
ArriVent Biopharma
Mar 2023Participated
$155 MSeries B
InxMed
Mar 2022Participated
$50 MSeries B
Meditrust
Aug 2021Participated
$309 MSeries C
OnCusp Therapeutics
Jun 2021Participated
$25 MSeed
LakeShore Biopharma
Mar 2021Participated
$130 MSeries B
InventisBio
Sep 2020Participated
$147 MSeries D
Akeso
Nov 2019Participated
$150 MSeries D
Orange Dental
Jan 2024Participated
$130 MSeries B
ArriVent Biopharma
Mar 2023Participated
$155 MSeries B
InxMed
Mar 2022Participated
$50 MSeries B
Meditrust
Aug 2021Participated
$309 MSeries C
OnCusp Therapeutics
Jun 2021Participated
$25 MSeed
LakeShore Biopharma
Mar 2021Participated
$130 MSeries B
InventisBio
Sep 2020Participated
$147 MSeries D
Akeso
Nov 2019Participated
$150 MSeries D
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

AIHC Capital: 8 funding rounds are recorded in the selected participation categories.All available history.
AIHC Capital: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series B04
Series C+03

Monthly Deal Activity

AIHC Capital: 8 deals are recorded across 84 months.All available history.
AIHC Capital: 8 deals are recorded across 84 months. All available history
MonthDeals
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '211
Jul '210
Aug '211
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

AIHC Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

AIHC Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Fintech2
AI & Machine Learning1
Professional Services1
Consumer & Lifestyle1

Deal Size Distribution

AIHC Capital: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

AIHC Capital: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M1
$100M-$250M5
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

AIHC Capital: China has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 5 of 5 regions; European countries are grouped as Europe.

AIHC Capital: China has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
China3
United States2
South Africa1
Hong Kong1
Russian Federation1
AIHC Capital: 20 co-investors are shown, with OrbiMed sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

AIHC Capital: 20 co-investors are shown, with OrbiMed sharing 5 recorded deals. All available history
Co-investorShared deals
OrbiMed5
Lilly Asia Ventures3
3W Capital2
Adjuvant Capital2
Eight Roads Ventures2
F-Prime Capital2
Haitong International2
Janchor Partners2
Lake Bleu Capital2
MSA Capital2
Oceanpine Capital2
Superstring Capital2
Advantech Capital1
Bank of China Group Investment1
Boyu Capital1
Catalio Capital Management1
CDG International1
China Everbright1
China Renaissance1
CICC Capital1

Investment Strategy

AIHC Capital: Led accounts for 0% and participating for 100% of round participation.All available history.
AIHC Capital: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating8100%
AIHC Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
AIHC Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

No team members found for this fund.